Axiom/Source Library
+ New intake
← Source Library

Selank — Peptide Dosing Protocols reference

patient_educationexpert_opinion · status: needs_provider_review
Details
Author:
Citation:
Summary (generated — provider review required)

Selank Peptide Dosing Guide: Nasal vs SubQ, Protocol & Safety (2026) Shop Protocols Stacks A–Z Index Email Updates Home Protocols Selank Dosing Peptide Guide: Nasal vs SubQ, Protocol & Safety (2026) Protocol / Research Dosing Guide Selank Dosing Peptide Guide: Nasal vs SubQ, Protocol & Safety (2026) An evidence-based Selank protocol dosing guide covering nasal spray vs subcutaneous use, cycle length, and safety considerations for this anxiety-focused nootropic peptide. By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Verified Supplier Peptide Partners Selank Supply View Supplier Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status Selank Comparisons Related Protocols Blood Tests FAQ References Selank Quick Start Selank is a Russian-developed peptide that is studied for anxiety relief and mild focus support. It is also called TP-7.

The original source document remains the source of truth. Generated summaries are not authoritative.

Linked assets (11) · phenotypes (0)

evidence_reference, dosing_reference, mechanism, safety_reference, monitoring_reference

Findings (157) · awaiting review (121)
dosing · pending
Outside Russia, research-use Selank is most often supplied as a lyophilized powder for either subcutaneous injection or for users who prepare their own intranasal solution.
dosing · pending
William Seeds has documented injectable Selank doses of 100-300 mcg per day as appropriate and well tolerated for most subjects.
dosing · pending
Nasal spray at 600-2,700 mcg per day, split into 2-3 doses.
dosing · pending
Selank Peptide Dosing Guide: Nasal vs SubQ, Protocol & Safety (2026) Shop Protocols Stacks A–Z Index Email Updates Home Protocols Selank Dosing Peptide Guide: Nasal vs SubQ, Protocol & Safety (2026) Protocol / Research Dosing Guide Selank Dosing Peptide Guide: Nasal vs SubQ, Protocol & Safety (2026) An evidence-based Selank protocol dosing guide covering nasal spray vs subcutaneous use, cycle length, and safety considerations for this anxiety-focused nootropic peptide.
dosing · pending
By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Verified Supplier Peptide Partners Selank Supply View Supplier Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status Selank Comparisons Related Protocols Blood Tests FAQ References Selank Quick Start Selank is a Russian-developed peptide that is studied for anxiety relief and mild focus support.
regulatory · pending
Selank is approved in Russia for anxiety disorders and neurasthenia, where it is sold as a nasal spray.
regulatory · pending
It is not FDA-approved in the United States.
dosing · pending
The first is subcutaneous injection (SubQ) at 250-500 mcg per day.
dosing · pending
The second is intranasal dosing at 600-2,700 mcg per day, split into 2 or 3 sprays.
dosing · pending
Route Subcutaneous injection (SubQ) or intranasal nasal spray.
dosing · pending
Schedule SubQ: once daily for 4 weeks, then 4 weeks off.
regulatory · pending
Not FDA-approved.
regulatory · pending
Selank is not FDA-approved.
dosing · pending
Selank Dosing Protocol & Schedule Selank protocols come in two main shapes.
dosing · pending
Each tab shows the dosing pattern, cycle length, and titration plan for that format.
dosing · pending
Subcutaneous (SubQ) Intranasal Once-daily injection at 250-500 mcg.
dosing · pending
esearch-use SubQ schedule is 4 weeks on at 250-500 mcg per day, followed by 4 weeks off.
dosing · pending
SubQ Selank Cycle Outline Phase Initiation Duration Weeks 1-2 Daily Dose 250-300 mcg Notes Once daily.
dosing · pending
Phase Maintenance Duration Weeks 3-4 Daily Dose 400-500 mcg Notes Step up only if the lower dose felt safe and stable.
dosing · pending
Phase Cycle off Duration Weeks 5-8 Daily Dose 0 mcg Notes Four-week rest used in community protocols.
dosing · pending
Phase Repeat Duration Weeks 9-12 Daily Dose 300-500 mcg Notes Resume at the dose that worked best.
dosing · pending
Phase Duration Daily Dose Notes Initiation Weeks 1-2 250-300 mcg Once daily.
dosing · pending
Maintenance Weeks 3-4 400-500 mcg Step up only if the lower dose felt safe and stable.
dosing · pending
Cycle off Weeks 5-8 0 mcg Four-week rest used in community protocols.
dosing · pending
Intranasal Schedule Russian clinical protocols use a 14-21 day course at 600-2,700 mcg per day, split into 2 or 3 sprays.
dosing · pending
ation 14-21 days Daily Dose 600-2,700 mcg Notes Split into 2-3 daily sprays per Russian clinical practice.
dosing · pending
Phase Washout Duration 1-3 weeks Daily Dose 0 mcg Notes Rest period before repeating the course.
dosing · pending
Phase Duration Daily Dose Notes Standard course 14-21 days 600-2,700 mcg Split into 2-3 daily sprays per Russian clinical practice.
dosing · pending
Washout 1-3 weeks 0 mcg Rest period before repeating the course.
dosing · pending
Why Titration Matters Selank has a mild safety profile, but lower starting doses help find the dose where the calming effect shows up without extra side effects.
dosing · pending
Some users feel best at 250-300 mcg.
dosing · pending
Others need 500 mcg before they notice anxiolytic relief.
dosing · pending
If a dose is missed, take the next scheduled dose and do not double up.
dosing · pending
Selank's effects build across days of regular use, so one missed dose rarely matters.
dosing · pending
Selank Supplies Needed Plan supplies based on the SubQ schedule above: one daily injection at 250-500 mcg from a 30 mg vial.
dosing · pending
Peptide Vials (SubQ) 30 mg lyophilized vial.
dosing · pending
One vial covers most 4-week and 8-week SubQ planning ranges with margin; longer or higher-dose cycles may require a second vial.
dosing · pending
Cycle length Planning note 4-8 weeks 1 x 30 mg vial 4 weeks: 28 doses need 7-14 mg total at 250-500 mcg per day, so one 30 mg vial covers a full 4-week cycle with margin.; 8 weeks: 56 doses need 14-28 mg total at 250-500 mcg per day, so one 30 mg vial covers the range with limited margin at the high end.
dosing · pending
12 weeks 1-2 x 30 mg vials 84 doses need 21 mg total at 250 mcg per day or 42 mg total at 500 mcg per day.
dosing · pending
4-8 weeks 1 x 30 mg vial 4 weeks: 28 doses need 7-14 mg total at 250-500 mcg per day, so one 30 mg vial covers a full 4-week cycle with margin.; 8 weeks: 56 doses need 14-28 mg total at 250-500 mcg per day, so one 30 mg vial covers the range with limited margin at the high end.
Processing

Processed into 26 searchable sections.